Insulin glargine effectively achieves glycemic control and improves insulin resistance in patients with early type 2 diabetes that exhibit a high risk for cardiovascular disease

In the present study, the clinical efficacy and safety of administering insulin glargine to early type 2 diabetes (T2D) mellitus patients with a high risk for cardiovascular disease were assessed. A total of 42 early T2D patients at a high risk for cardiovascular disease were randomly divided into a...

Descripción completa

Detalles Bibliográficos
Autores principales: LI, JILING, FENG, ZHENGPING, LI, QIFU, HE, YAN, ZHAO, CHANGHONG, HE, JUN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061209/
https://www.ncbi.nlm.nih.gov/pubmed/24944613
http://dx.doi.org/10.3892/etm.2014.1688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061209/
https://www.ncbi.nlm.nih.gov/pubmed/24944613
http://dx.doi.org/10.3892/etm.2014.1688

Ejemplares similares